MRC and Articulate find corporate parents

Article

MRC and Articulate find corporate parentsDOC issues directive to continue production, howeverMedical transcriptionist firm MedQuist has signed a definitive agreement to acquire The MRC Group, a Cleveland-based voice recognition firm. The

MRC and Articulate find corporate parents

DOC issues directive to continue production, however

Medical transcriptionist firm MedQuist has signed a definitive agreement to acquire The MRC Group, a Cleveland-based voice recognition firm. The transaction would create a company with annual revenues of greater than $260 million.

The acquisition, which is subject to regulatory and shareholder approval, is expected to close during the fourth quarter. It would be accounted for as a pooling of interest, and MRC shareholders would own 26.5% of the company following the transaction, according to MedQuist of Marlton, NJ.

MedQuist chairman and CEO David Cochen will retain his titles with the new company, as will MedQuist president and COO John Donohoe. MRC chairman and CEO Edward Samek will serve as vice chairman, and MRC president and COO Dennis Byerly will become president of the company's eastern region.

In a related development, Salt Lake City, UT-based speech recognition firm fonix has purchased all of the outstanding shares of Articulate Systems, which provides the PowerScribe Radiology product family to The MRC Group. Based in Boston, Articulate Systems becomes a wholly owned subsidiary of fonix.

The company also reports continued commercial success with PowerScribe Radiology. In the eight months since the product was brought to market, fonix/ASI has acquired more than 20 healthcare institutions as clients, including Duke University, Emory University Healthcare, University of Alabama-Birmingham, Cornell Medical Center, Virginia Beach Hospital, Wishard Hospital, State University of New York-Stonybrook, and the National Institutes of Health.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.